Nerve Growth Factor

New England Journal of Medicine

Volumn 297, Issue 22, 1977, Pages 1211-1218

  Mobley, William C ^a,b   Server, Alfred C ^a,b   Ishii, Douglas N ^a,b   Riopelle, Richard J ^a,b   Shooter, Eric M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; SENSORY NEUROPATHY; SHY DRAGER SYNDROME; THERAPY;

ADRENAL GLAND NEOPLASMS; ADULT; ANIMALS; CULTURE TECHNIQUES; HUMANS; HYPOTENSION, ORTHOSTATIC; INFANT; MALE; NEOPLASM REGRESSION, SPONTANEOUS; NERVE GROWTH FACTORS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NEUROBLASTOMA; NEUROFIBROMATOSIS 1; PHEOCHROMOCYTOMA; RECEPTORS, SENSORY;

EID: 0017666096     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197712012972205     Document Type: Review

References (62)

1. Jaffe N: Neuroblastoma: review of the literature and an examination of factors contributing to its enigmatic character. Cancer Treat Rev 3: 61–82, 1976
2. Pochedly C: Neuroblastoma. Acton, Massachusetts, Publishing Sciences Group, 1976
3. Prasad KN: Differentiation of neuroblastoma cells in culture. Biol Rev 50: 129–165, 1975
4. Bolande RP: The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment. Hum Pathol 5: 409–429, 1974
5. Leung FY, Griffiths J: Use of plasma catecholamine values in diagnosing pheochromocytoma and neuroblastoma. Can Med Assoc J 111: 1321–1322, 1974
6. Everson TC: Spontaneous regression of cancer. Ann NY Acad Sci 114: 721–735, 1964
7. Abell MR, Hart WR, Olson JR: Tumors of the peripheral nervous system. Hum Pathol 1: 503–551, 1970
8. Bolande RP: Benignity of neonatal tumors and concept of cancer repression in early life. Am J Dis Child 122: 12–14, 1971
9. Beckwith JB, Perrin EV: In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am J Pathol 43: 1089–1104, 1963
10. Turkel SB, Itabashi HH: The natural history of neuroblastic cells in the fetal adrenal gland. Am J Pathol 76: 225–244, 1974
11. Grace JT Jr: Clinical aspects of immunity in untreated cancer. Ann NY Acad Sci 114: 736–746,1964
12. Martin RF, Beckwith JB: Lymphoid infiltrates in neuroblastomas: their occurrence and prognostic significance. J Pediatr Surg 3: 161–164, 1968
13. Bill AH: The implications of immune reactions to neuroblastoma. Surgery 66: 415–418, 1969
14. Hellström IE, Hellström KE, Pierce GE, et al: Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci USA 60: 1231–1238, 1968
15. Bansal SC, Hargreaves R, Sjögren HO: Facilitation of polyoma tumor growth in rats by blocking sera and tumor eluate. Int J Cancer 9: 97–108, 1972
16. Bill AH: Immune aspects of neuroblastoma: current information. Am J Surg 122: 142–147, 1971
17. Takasugi M, Mickey MR, Terasaki PI: Studies on specificity of cell-mediated immunity to human tumors. J Natl Cancer Inst 53: 1527–1538, 1974
18. Murray MR, Stout AP: Distinctive characteristics of the sympathico blastoma cultivated in vitro: a method for prompt diagnosis. Am J Pathol 23: 429–441, 1947
19. Goldstein MN, Burdman JA, Journey LJ: Long-term tissue culture of neuroblastomas. II. Morphologic evidence for differentiation and maturation. J Natl Cancer Inst 32: 165–174, 1964
20. Waris T, Rechardt L, Waris P: Differentiation of neuroblastoma cells induced by nerve growth factor in vitro. Experientia 29: 1128–1129, 1973
21. Kolber AR, Goldstein MN, Moore BW: Effect of nerve growth factor on the expression of colchicine-binding activity and 14–3–2 protein in an established line of human neuroblastoma. Proc Natl Acad Sci USA 71: 4203–4207, 1974
22. Burdman JA, Goldstein MN: Long-term tissue culture of neuroblastoma. III. In vitro studies of a nerve growth-stimulating factor in sera of children with neuroblastoma. J Natl Cancer Inst 33: 123–133, 1964
23. Kumar S, Steward JK, Waghe M: Nerve-growth factor in human tumors. Lancet 2: 234, 1972
24. Greenberg RE, Winick M, Reilly TA: Studies of a nerve-growth-promoting protein. I. Demonstration in human fetal tissue. J Pediatr 63: 753–754, 1963
25. Bill AH, Seibert ES, Beckwith JB, et al: Nerve growth factor and nerve growth-stimulating activity in sera from normal and neuroblastoma patients. J Natl Cancer Inst 43: 1221–1230, 1969
26. Waghe M, Kumar S, Steward JK: Nerve growth factor in human sera. J Pediatr Surg 5: 14–17, 1970
27. Kumar S, Steward JK, Waghe M, et al: The administration of the nerve growth factor to children with widespread neuroblastoma. J Pediatr Surg 5: 18–22, 1970
28. Goldstein MN, Pinkel D: Long-term tissue culture of neuroblastomas. J Natl Cancer Inst 20: 675–680, 1958
29. Murphy RA, Pantazis NJ, Arnason BGW, et al: Secretion of a nerve growth factor by mouse neuroblastoma cells in culture. Proc Natl Acad Sci USA 72: 1895–1898, 1975
30. Reynolds CP, Pérez-Polo JR: Human neuroblastoma: glial induced morphological differentiation. Neurosci Lett 1: 91–97, 1975
31. Nelson P, Christian C, Nirenberg M: Synapse formation between clonal neuroblastoma x glioma hybrid cells and striated muscle cells. Proc Natl Acad Sci USA 73: 123–127, 1976
32. Amano T, Richelson E, Nirenberg M: Neurotransmitter synthesis by neuroblastoma clones. Proc Natl Acad Sci USA 69: 258–263, 1972
33. Knapp S, Mandell AJ: Serotonin biosynthetic capacity of mouse C1300 neuroblastoma cells in culture. Brain Res 66: 547–551, 1974
34. Prasad KN, Mandal B, Kumar S: Demonstration of cholinergic cells in human neuroblastoma and ganglioneuroma. J Pediatr 82: 677–679, 1973
35. Goldstein MN, Brodeur GM, Ross D: The effect of nerve growth factor and dibutyryl cyclic AMP on acetylcholinesterase in human and mouse neuroblastomas. Anat Rec 175: 330, 1973
36. Tischler AS, Dichter MA, Biales B, et al: Neural properties of cultured human endocrine tumor cells of proposed neural crest origin. Science 192: 902–904, 1976
37. Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System. Fourth edition. London, Edward Arnold, 1977
38. Schenkein I, Bueker ED, Helson L, et al: Increased nerve-growthstimulating activity in disseminated neurofibromatosis. N Engl J Med 290: 613–614, 1974
39. Tischler AS: Quantitation of nerve-growth-stimulating activity. N Engl J Med 290: 1203, 1974
40. Siggers DC, Boyer SH, Eldridge R: Nerve-growth factor in disseminated neurofibromatosis. N Engl J Med 292: 1134, 1975
41. Siggers DC: Nerve growth factor and some inherited neurological conditions. Proc R Soc Med 69: 183–184, 1976
42. Dyck P, Ohta M: Neuronal atrophy and degeneration predominantly affecting peripheral sensory neurons, Peripheral Neuropathy. Vol 2. Edited by PJ Dyck, PK Thomas, EH Lambert. Philadelphia, Saunders, 1975, pp 791–824
43. Appenzeller O: The Autonomic Nervous System: An introduction to basic and clinical concepts. Second edition. New York, American Elsevier, 1976
44. Johnson RH, Spalding JM: Disorders of the Autonomic Nervous System. Philadelphia, Davis, 1974
45. Cohen P, Solomon NH: Familial dysautonomia: case report with autopsy. J Pediatr 46: 663–670, 1955
46. Brown WJ, Beauchemin JA, Linde LM: A neuropathological study of familial dysautonomia (Riley-Day syndrome) in siblings. J Neurol Neurosurg Psychiatry 27: 131–139, 1964
47. Pearson J, Budzilovich G, Finegold MJ: Sensory, motor and autonomic dysfunction: the nervous system in familial dysautonomia. Neurology (Minneap) 21: 486–493, 1971
48. Aguayo AJ, Nair CPV, Bray GM: Peripheral nerve abnormalities in the Riley-Day syndrome: findings in a sural nerve biopsy. Arch Neurol 24: 106–116, 1971
49. Pearson J, Axelrod F, Dancis J: Current concepts of dysautonomia: neuropathological defects. Ann NY Acad Sci 228: 288–300, 1974
50. Brown JW, Podosin R: A syndrome of the neural crest. Arch Neurol 15: 294–301, 1966
51. Pinsky L, DiGeorge AM: Congenital familial sensory neuropathy with anhidrosis. J Pediatr 68: 1–13, 1966
52. Swanson AG: Congenital insensitivity to pain with anhydrosis: a unique syndrome in two male siblings. Arch Neurol 8: 299–306, 1963
53. Swanson AG, Buchan GC, Alvord EC Jr: Anatomic changes in congenital insensitivity to pain: absence of small primary sensory neurons in ganglia, roots, and Lissauer's tract. Arch Neurol 12: 12–18, 1965
54. Greenfield JG: The Spino-cerebellar Degenerations. Oxford, Blackwell, 1954
55. Siggers DC, Rogers JG, Boyer SH, et al: Increased nerve-growth-factor β-chain cross-reacting material in familial dysautonomia. N Engl J Med 295: 629–634, 1976
56. Black IB, Petito CK: Catecholamine enzymes in the degenerative neurological disease idiopathic orthostatic hypotension. Science 192: 910–912, 1976
57. Black IB, Hendry IA, Iversen LL: Effects of surgical decentralization and nerve growth factor on the maturation of adrenergic neurons in a mouse sympathetic ganglion. J Neurochem 19: 1367–1377, 1972
58. Thoenen H, Saner A, Angeletti PU, et al: Increased activity of choline acetyltransferase in sympathetic ganglia after prolonged administration of nerve growth factor. Nature [New Biol] 236: 26–28, 1972
59. Levi-Montalcini R: Nerve-growth factor in familial dysautonomia. N Engl J Med 295: 671–673, 1976
60. Greene LA: A dissociated cell culture bioassay for nerve growth factor. Neurobiology 4: 286–292, 1974
61. Kahn CR, Megyesi K, Bar RS, et al: Receptors for peptide hormones: new insights into the pathophysiology of disease states in man. Ann Intern Med 86: 205–219, 1977
62. Angeletti RH: Nerve growth factor (NGF) from snake venom and mouse submaxillary gland: interaction with serum proteins. Brain Res 12: 234–237, 1969